The future of HIV testing in eastern and southern Africa: Broader scope, targeted services
A Grimsrud, L Wilkinson, P Ehrenkranz, S Behel… - Plos …, 2023 - journals.plos.org
The future of HIV testing in eastern and southern Africa: Broader scope, targeted services |
PLOS Medicine Skip to main content Advertisement PLOS Medicine Browse Current Issue …
PLOS Medicine Skip to main content Advertisement PLOS Medicine Browse Current Issue …
Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review
Background: Dolutegravir (DTG) is a cornerstone of global antiretroviral (ARV) therapy
(ART) due to its high efficacy and favorable tolerability. However, limited data exist regarding …
(ART) due to its high efficacy and favorable tolerability. However, limited data exist regarding …
Reasons for disengagement from antiretroviral care in the era of “Treat All” in low‐or middle‐income countries: a systematic review
RM Burke, HM Rickman, C Pinto… - Journal of the …, 2024 - Wiley Online Library
Introduction Disengagement from antiretroviral therapy (ART) care is an important reason
why people living with HIV do not achieve viral load suppression become unwell. Methods …
why people living with HIV do not achieve viral load suppression become unwell. Methods …
Experiences and Preferences in Zambia and South Africa for Delivery of HIV Treatment During a Client's First Six Months: Results of the PREFER Study's Cross …
N Mutanda, A Morgan, A Kamanga, L Sande… - AIDS and Behavior, 2025 - Springer
Disengagement from antiretroviral therapy (ART) is highest in the early treatment period (≤
6 months after initiation/re-initiation), but low intensity models designed to increase retention …
6 months after initiation/re-initiation), but low intensity models designed to increase retention …
Risk of Emergent Dolutegravir Resistance Mutations In People Living With HIV: A Rapid Scoping Review
Background Dolutegravir (DTG) is a cornerstone of global antiretroviral (ARV) therapy (ART)
due to its high efficacy and favorable tolerability. However, limited data exist regarding the …
due to its high efficacy and favorable tolerability. However, limited data exist regarding the …
Prior antiretroviral therapy exposure among clients presenting for HIV treatment initiation in South Africa: an exploratory mixed-methods study using multiple indicators …
Background The era of universal treatment for HIV has seen high rates of disengagement
from antiretroviral therapy (ART) programs and re-engagement after interruptions, with …
from antiretroviral therapy (ART) programs and re-engagement after interruptions, with …
Drivers of disengagement from care during the first six months on antiretroviral therapy for HIV in South Africa: a mixed-methods study
Introduction: For clients on HIV treatment in sub-Saharan Africa, disengagement from HIV
care in the early treatment period is a critical obstacle to achieving UNAIDS's second 95 …
care in the early treatment period is a critical obstacle to achieving UNAIDS's second 95 …
Systematic Review and Meta-Analysis of Retention and Disengagement After Initiation on Antiretroviral Therapy in Low-and Middle-Income Countries After the …
Background We previously published a systematic review evaluating retention in care after
antiretroviral therapy treatment initiation among adults in low-and middle-income countries …
antiretroviral therapy treatment initiation among adults in low-and middle-income countries …
Experiences and preferences in Zambia and South Africa for delivery of HIV treatment during a clients first six months: a cross-sectional survey
N Mutanda, A Morgan, A Kamanga, L Sande… - medRxiv, 2024 - medrxiv.org
Background: Disengagement from antiretroviral therapy (ART) is highest in the early
treatment period (≤ 6 months after initiation/re-initiation), but low intensity models designed …
treatment period (≤ 6 months after initiation/re-initiation), but low intensity models designed …
Costs and cost-effectiveness of interventions to improve HIV treatment adherence in Cape Town, South Africa
RL West - 2024 - search.proquest.com
Background: Improving adherence to antiretroviral therapy (ART) is crucial for achieving HIV
epidemic control in South Africa. The SUSTAIN trial aims to identify the most cost-effective …
epidemic control in South Africa. The SUSTAIN trial aims to identify the most cost-effective …